The Effect of Rupatadine on Lung Histopathology in a Murine Model of Chronic Asthma

References

• Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA). Revised 2009. Available at: http://www.ginasthma.org.
   Google Scholar
• Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, Helms PJ, Hunt J, Liu A, Papadopoulos N, Platts-Mills T, Pohunek P, Simons FE, Valovirta E, Wahn U, Wildhaber J. European pediatric asthma group: Diagnosis and treatment of asthma in childhood: A Practall consensus report. Allergy 2008; 63:5–34.
   PubMed Web of Science ®Google Scholar
• Holgate ST, Arshad HS, Roberts GC, Howarth PH, Thurner P, Davies DE. A new look at the pathogenesis of asthma. Clin Sci (Lond) 2009; 23(118):439–450.
   Google Scholar
• Folli C, Descalzi D, Scordamaglia F, Riccio AM, Gamalero C, Canonica GW. New insights into airway remodelling in asthma and its possible modulation. Curr Opin Allergy Clin Immunol 2008; 8:367–375.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: An update. Pharmacol Rev 1998; 50:515–596.
   PubMed Web of Science ®Google Scholar
• Bousquet J, van Cauwenberge P, Aït Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J, Bunnag C, Canonica GW, Carlsen KH, Chen YZ, Cruz AA, Custovic A, Demoly P, Dubakiene R, Durham S, Fokkens W, Howarth P, Kemp J, Kowalski ML, Kvedariene V, Lipworth B, Lockey R, Lund V, Mavale-Manuel S, Meltzer EO, Mullol J, Naclerio R, Nekam K, Ohta K, Papadopoulos N, Passalacqua G, Pawankar R, Popov T, Potter P, Price D, Scadding G, Simons FE, Spicak V, Valovirta E, Wang DY, Yawn B, Yusuf O. Pharmacologic and anti IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy 2006; 61:1086–1098.
   PubMed Web of Science ®Google Scholar
• Mullol J, Bousquet J, Bachert C, Canonica WG, Gimenez-Arnau A, Kowalski ML, Martí-Guadaño E, Maurer M, Picado C, Scadding G, Van Cauwenberge P. Rupatadine in allergic rhinitis and chronic urticaria. Allergy 2008; 63(Suppl 87):5–28.
   PubMed Web of Science ®Google Scholar
• Simons FER. Is antihistamine (H1-receptor antagonist) therapy useful in clinical asthma? Clin Exp Allergy 1999; 29(Suppl 3):98–104.
   PubMed Web of Science ®Google Scholar
• Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther 1997; 280:114–121.
   PubMed Web of Science ®Google Scholar
• Kay AB. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. Eur J Respir Dis Suppl 1983; 129:1– 44.
   PubMedGoogle Scholar
• Herz U, Lumpp U, Da Palma JC, Enssle K, Takatsu K, Schnoy N, Daser A, Kottgen E, Wahn U, Renz H. The relevance of murine animal models to study the development of allergic bronchial asthma. Immunol Cell Biol 1996; 74:209–217.
   PubMed Web of Science ®Google Scholar
• Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: Selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53:849–856.
   PubMed Web of Science ®Google Scholar
• Henderson WR Jr, Chiang GK, Tien YT, Chi EY. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 2006; 173:718–728.
   PubMed Web of Science ®Google Scholar
• Firinci F, Karaman M, Baran Y, Bagriyanik A, Ayyildiz ZA, Kiray M, Kozanoglu I, Yilmaz O, Uzuner N, Karaman O. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011; 11:1120–1126.
   PubMedGoogle Scholar
• Lloyd CM, Robinson DS. Allergen-induced airway remodelling. Eur Respir J 2007; 29:1020–1032.
   PubMedGoogle Scholar
• James A. Airway remodeling in asthma. Curr Opin Pulm Med 2005; 11:1–6.
   PubMed Web of Science ®Google Scholar
• Girodet PO, Ozier A, Bara I, de Lara JM, Marthan R, Berger P. Airway remodeling in asthma: New mechanisms and potential for pharmacological intervention. Pharmacol Ther 2011; 130:325–337.
   PubMed Web of Science ®Google Scholar
• Grant JA, Nicodemus CF, Findlay SR, Glovsky MM, Grossman J, Kaiser H, Meltzer EO, Mitchell DQ, Pearlman D, Selner J, Settipane G, Silvers W. Cetirizine in patients with seasonal rhinitis and concomitant asthma: Prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995; 95:923–932.
   PubMed Web of Science ®Google Scholar
• Busse WW, Middleton E, Storms W, Dockhorn RJ, Chu TJ, Grossman J, Weiler JM, Bronsky EA, Mansfield LE, Bell TD, Hemsworth GR, Perhach JL, D'Eletto TA, Dam A. Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med 1996; 153:122–127.
   PubMed Web of Science ®Google Scholar
• Baena-Cagnani CE, Berger WE, Du Buske LM, Gurné SE, Stryszak P, Lorber R, Danzig M. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003; 130:307–313.
   PubMed Web of Science ®Google Scholar
• Bryce PJ, Geha R, Oettgen HC. Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. J Allergy Clin Immunol 2003; 112:149–158.
   PubMed Web of Science ®Google Scholar
• Bachert C, Maspero J. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma. J Asthma 2011; 48:965–973.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams. Allergic Rhinitis and its impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen. Allergy 2008; 63(Suppl 86):8–160.
   PubMed Web of Science ®Google Scholar
• Vasiadi M, Kalogeromitros D, Kempuraj D, Clemons A, Zhang B, Chliva C, Makris M, Wolfberg A, House M, Theoharides TC. Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli. Int Arch Allergy Immunol 2010; 151:38–45.
   PubMed Web of Science ®Google Scholar
• Merlos M, Ramis I, Balsa D, Queralt M, Brazis P, Puigdemont A. Inhibitory effect of rupatadine on TNF-α release from human monocytes and mast cell line HMC-1. J Allergy Clin Immunol 2000; 105(suppl 1):S62.
   Google Scholar
• Merlos M, Giral M, Balsa D, Ferrando R, Garcia-Rafanell J, Forn J. Rupatadine inhibits the eosinophil recruitment in BAL fluid of ovalbumin-sensitized guinea pigs. J Allergy Clin lmmunol 1998; 101(Suppl 1):S218.
   Google Scholar
• Barrón S, Ramis I, Merlos M. Effect of rupatadine on lymphocyte cytokine production. Allergy Clin Immunol Int 2005; 1(Suppl 1):427.
   Google Scholar
• Kasperska-Zajac A, Brzoza Z, Rogala B. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma. Inflammation 2008; 31:112–120.
   PubMed Web of Science ®Google Scholar
• Lin CC, Lin CY. Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration. J Asthma 1997; 34:153–160.
   PubMed Web of Science ®Google Scholar
• Spence DP, Johnston SL, Calverley PM, Dhillon P, Higgins C, Ramhamadany E, Turner S, Winning A, Winter J, Holgate ST. The effect of the orally active platelet activating factor antagonist WEB 2086 in the treatment of asthma. Am J Respir Crit Care Med 1994; 149:1142–1148.
   PubMedGoogle Scholar
• Kuitert LM, Angus RM, Barnes NC, Barnes PJ, Bone MF, Chung KF, Fairfax AJ, Higenbotham TW, O’Connor BJ, Piotrowska B, Rozniecki J, Uden S, Hayden E, Willard CJ. Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. Am J Respir Crit Care Med 1995; 151:1331–1335.
   PubMed Web of Science ®Google Scholar
• Henig NR, Aitken ML, Liu MC, Yu AS, Henderson WR Jr. Effect of recombinant human platelet-activating factor acetylhydrolase on allergen-induced asthmatic responses. Am J Respir Crit Care Med 2000; 162:523–527.
   PubMed Web of Science ®Google Scholar